Cape Investment Advisory, Inc. Amgen Inc Transaction History
Cape Investment Advisory, Inc.
- $256 Billion
- Q4 2024
A detailed history of Cape Investment Advisory, Inc. transactions in Amgen Inc stock. As of the latest transaction made, Cape Investment Advisory, Inc. holds 735 shares of AMGN stock, worth $233,597. This represents 0.07% of its overall portfolio holdings.
Number of Shares
735
Previous 723
1.66%
Holding current value
$233,597
Previous $233 Million
17.76%
% of portfolio
0.07%
Previous 0.09%
Shares
8 transactions
Others Institutions Holding AMGN
# of Institutions
3,176Shares Held
419MCall Options Held
8.25MPut Options Held
6.39M-
Vanguard Group Inc Valley Forge, PA52.7MShares$16.8 Billion0.25% of portfolio
-
Black Rock Inc. New York, NY46MShares$14.6 Billion0.33% of portfolio
-
State Street Corp Boston, MA29.4MShares$9.35 Billion0.31% of portfolio
-
Morgan Stanley New York, NY14.6MShares$4.63 Billion0.27% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA13.2MShares$4.2 Billion0.65% of portfolio
About AMGEN INC
- Ticker AMGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 534,931,008
- Market Cap $170B
- Description
- Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...